A detailed history of Carrera Capital Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Carrera Capital Advisors holds 1,195 shares of ABBV stock, worth $243,875. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,195
Previous 12,480 90.42%
Holding current value
$243,875
Previous $2.46 Billion 91.38%
% of portfolio
0.05%
Previous 0.6%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

SELL
$164.99 - $203.87 $1.86 Million - $2.3 Million
-11,285 Reduced 90.42%
1,195 $212 Million
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $343,080 - $417,397
2,094 Added 20.16%
12,480 $2.46 Billion
Q2 2024

Aug 27, 2024

BUY
$154.79 - $180.76 $1.61 Million - $1.88 Million
10,386 New
10,386 $1.78 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $361B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Carrera Capital Advisors Portfolio

Follow Carrera Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carrera Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Carrera Capital Advisors with notifications on news.